TOPRA Summit 2021

Focusing on the changes and disruptions that COVID-19 has brought, this year's Summit will look at the new norm and where we should go from here.

COVID-19 made the impossible possible – where do we go from here?

When: 20 May 2021
Where: Online
Time: 12:30 - 17:30 (GMT+1) / 13:30 - 18:30 (CET+1)

TOPRA's Annual Summit is a commitment to advancing regulatory thinking.  Our yearly gathering gives influencers and senior regulatory professionals a platform to debate the future of the profession, evaluate suggestions on how processes and techniques might develop to improve the delivery of products and innovations to get to market.  The post-meeting Summit report, often consulted and widely referred to, will be made available to the profession and interested stakeholders after the event.  


Regulators and the pharma sector have has achieved much during the ongoing pandemic. The COVID-19 (SARS-CoV-2) virus has, to a great extent, disrupted our ways of working. Processes have changed and become more agile. New technologies have been deployed for conducting remote inspections and remote clinical trials. The ways we interact between stakeholders and within our own organisations have dramatically changed. A new norm is inevitably upon us!

Join us online this year to discuss how the catalyst of COVID-19 disruption can lift regulatory science to the next level. What agilities should stay and what could go, and where do we go from here? 

Information sessions

Challenging presentations from experts will help set the scene for further discussions. More information about the sessions will be available soon.

Impact Sessions

Participants will participate in smaller breakout groups for in-depth discussions and development of proposals for presentation in the Summit whitepaper and sharing with key influencers.

You can find the programme here.


  • Nikolai Brun - Former Divisional Director at the DKMA, Denmark
  • Pär Tellner - Director, Regulatory, Drug development and Manufacturing, European Federation of Pharmaceutical Industries (EFPIA), Belgium
  • Rachel Mead - GCP Inspector, Medicines and Healthcare products Regulatory Agency (MHRA), UK

This meeting offers 5 CPD hours for successful completion.  To learn about why CPD is important, visit our Lifelong Learning page.


  • Members: £245+VAT*
  • Non-members: £295+VAT*

*VAT, if applicable, is charged at the rate of 20%.

Terms and conditions

Please read the training terms and conditions before booking this course. By booking a place on this course you are agreeing to the training terms and conditions.


Your company name
Your VAT country
Your VAT number
Important instructions before booking - If your company name or VAT number does not appear here or you would like to be invoiced using a different VAT number, please email

Register now